申请人:Hayter Raymond Barry
公开号:US20050054715A1
公开(公告)日:2005-03-10
The invention relates to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein A, R
1
, R
2
, R
3
, n and m are as described in the specification, useful in the treatment of
a disease or condition mediated through glucokinase (GLK), such as type 2 diabetes, The invention also relates to methods for preparing compounds of Formula (I) and their use as medicaments in the treatment of diseases mediated by glucokinase.
本发明涉及一种新型化合物,其化学式为(I)或其盐、溶剂化物或前药,其中A、R1、R2、R3、n和m如规范所述,在通过葡萄糖激酶(GLK)介导的疾病或病情的治疗中有用,例如2型糖尿病。本发明还涉及制备化合物(I)的方法及其作为药物治疗通过葡萄糖激酶介导的疾病的用途。